Drugmaker’s Business Tax Linked to Payments, Not Product Prices - Court News Ohio (.gov)
This article highlights a significant development where drugmaker's business tax is determined by their payments rather than the list prices of their products.
As previously mentioned, this change in taxation strategy has come into effect in the context of court rulings. Specifically, the focus on payments shifts the tax burden away from traditional product pricing, potentially impacting the pharmaceutical industry in substantial ways.